GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 124 filers reported holding GOSSAMER BIO INC in Q1 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $8,576 | -82.5% | 3,952 | -3.5% | 0.00% | -100.0% |
| Q3 2022 | $49,058 | +43.1% | 4,095 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $34,275 | -3.6% | 4,095 | 0.0% | 0.00% | +100.0% |
| Q1 2022 | $35,545 | -81.3% | 4,095 | -75.6% | 0.00% | -66.7% |
| Q4 2021 | $189,963 | -5.4% | 16,796 | +5.2% | 0.00% | 0.0% |
| Q3 2021 | $200,755 | +185.3% | 15,971 | +84.3% | 0.00% | +200.0% |
| Q2 2021 | $70,360 | -50.6% | 8,665 | -43.7% | 0.00% | -50.0% |
| Q1 2021 | $142,487 | -13.3% | 15,404 | -9.4% | 0.00% | 0.0% |
| Q4 2020 | $164,332 | -22.1% | 16,994 | 0.0% | 0.00% | -50.0% |
| Q3 2020 | $210,896 | +12.1% | 16,994 | +17.4% | 0.00% | +33.3% |
| Q2 2020 | $188,214 | +33.7% | 14,478 | +4.4% | 0.00% | 0.0% |
| Q1 2020 | $140,821 | -32.3% | 13,874 | +4.3% | 0.00% | 0.0% |
| Q4 2019 | $207,942 | -13.1% | 13,304 | -6.7% | 0.00% | -25.0% |
| Q3 2019 | $239,425 | +585.0% | 14,260 | +804.8% | 0.00% | +300.0% |
| Q2 2019 | $34,955 | – | 1,576 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 3,320,608 | $41,209,000 | 11.15% |
| Boxer Capital, LLC | 2,562,358 | $31,799,000 | 1.10% |
| Integral Health Asset Management, LLC | 200,000 | $2,482,000 | 0.76% |
| Palo Alto Investors LP | 1,077,200 | $13,368,000 | 0.73% |
| Artal Group S.A. | 2,358,968 | $29,275,000 | 0.71% |
| HHLR ADVISORS, LTD. | 7,420,974 | $92,094,000 | 0.70% |
| MASTERS CAPITAL MANAGEMENT LLC | 700,000 | $8,687,000 | 0.58% |
| Ikarian Capital, LLC | 582,494 | $7,229,000 | 0.52% |
| CLOUGH CAPITAL PARTNERS L P | 459,834 | $5,707,000 | 0.41% |
| Alyeska Investment Group, L.P. | 1,173,301 | $14,561,000 | 0.22% |